openPR Logo
Press release

Implantable Drug Delivery Devices Market is Expected to Exceed US$ 27 Billion by 2021

New York, May 10: Market Research Engine has published a new report titled as “Implantable Drug Delivery Devices Market by Applications, by Product Types and by Technology - Global Market Analysis and Forecast 2016 - 2021”

How Big is the Implantable Drug Delivery Devices Market?

The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/implantable-drug-delivery-devices-market

Implantable devices having many functions such as it vascular stents preserve flow of blood. The electro-stimulation devices control heart block spurious in the brain. Implantable drug delivery devices permit site specific drug management where that drug requires more. There has been rising union between drug therapies and implantable devices such as devices that carry drugs as prime action.

The major driving factors of implantable drug delivery devices market are as follows:

Driving factors for the global contraceptive drug delivery implants market
NGO and government initiatives to support contraceptive goods
Increasing frequency of unwanted pregnancies

Driving factors for the global intraocular drug delivery implants market
Increasing patient group for diabetic retinopathy and diabetes
Growing aging population globally

Driving factors for the global implantable drug infusion pumps market
High predominance of chronic pain causing disorders
Increasing frequency of colorectal cancer globally

Driving factors for the global brachytherapy seeds market
Appearance of new disease appliances
Growing prevalence of prostate cancer globally

Driving factors for the global coronary stents
Increasing many interventional cardiologists
Rising frequency of cardiovascular diseases

The restraining factors of implantable drug delivery devices market are as follows:

Strict CE and FDA approval norms.
The introduction of internal product substitutes, lawsuits and product recalls.

The implantable drug delivery devices market is segmented on the lines of its product type, technology, application and regional. Based on product type segmentation it covers implantable drug infusion pumps, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable contraceptive drug delivery devices, implantable bio absorbable stents and implantable coronary drug eluting stents. Under technology segmentation the implantable drug delivery devices market contains non biodegradable implantable drug delivery device technology and biodegradable implantable drug delivery device technology. The implantable drug delivery devices market is segmented on the lines of its application like oncology, birth control/ contraception, cardiovascular, ophthalmology and others such as chronic pain causing diseases and diabetes. The implantable drug delivery devices markets geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for implantable drug delivery devices and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.

3) Identifications of new market opportunities and targeted promotional plans for implantable drug delivery devices.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Implantable drug delivery devices with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market, current market trends and situations. Key players profiled in the report include Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide the buyers with a snapshot of the industry’s most influential players and potential market covered.

The Implantable drug delivery devices Market has been segmented as below:

By Product Type Analysis

Implantable drug infusion pumps
Implantable brachytherapy seeds
Implantable intraocular drug delivery devices
Implantable contraceptive drug delivery devices
Implantable bio absorbable stents
Implantable coronary drug eluting stents

By Technology Analysis

Non biodegradable implantable drug delivery device technology
Biodegradable implantable drug delivery device technology

By Application Analysis

Oncology
Birth control/ contraception
Cardiovascular
Ophthalmology
Other (chronic pain causing diseases, diabetes)

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all implantable drug delivery devices globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of implantable drug delivery devices data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Drug Delivery Devices Market is Expected to Exceed US$ 27 Billion by 2021 here

News-ID: 531856 • Views:

More Releases from MRE - Market Research Engine Reports

Texturized Vegetable Protein Market is Supposed to Reach at a CAGR of 6.50% by 2 …
New York, March 08, 2019: Market Research Engine has published a new report titled as “Texturized Vegetable Protein Market Size, By Product Type (Wheat, Soy, Pea, others), By Form (flakes, Slices, Chunks, Granules), By End Use (Commercial, Industrial, Household), By Region, Market Analysis Report, Forecast 2018-2024.” Changing lifestyle, increasing aging population, increasing health consciousness population, increasing demand for low carb food are some of the major key factors of the global
Workplace Transformation Market is Supposed to Reach US$ 18.06 Billion By 2024
New York, March 07, 2019: Workplace Transformation is the combination of human behavior, real estate and latest technology which results in reduction of overall costs with the elasticity of collaborative environment which facilitate efficiency and innovation. In this cutthroat competition and modern day work stations with these technologies make sure that applications are transmitted from a centralized location to an isolation environment on the objective device where you need to
Smart Worker Market Size is Projected to be Around US$ 5 Billion by 2024
New York, March 06, 2019: The Smart Worker Market is expected to exceed more than US$ 5 Billion by 2024 at a CAGR of 19% in the given forecast period. The scope of the report includes a detailed study of Smart Worker Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles

More Releases for Implantable

Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market. The study
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023. Nanomedical Devices Market - Segmentation The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of